Back to Search
Start Over
combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
- Source :
-
Annals of Oncology . Jun2019, Vol. 30 Issue 6, p927-933. 7p. 1 Diagram, 2 Charts. - Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 30
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 137208548
- Full Text :
- https://doi.org/10.1093/annonc/mdz076